1. Home
  2. L vs DGX Comparison

L vs DGX Comparison

Compare L & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loews Corporation

L

Loews Corporation

HOLD

Current Price

$107.52

Market Cap

21.2B

Sector

Finance

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$174.96

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
L
DGX
Founded
1969
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2B
20.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
L
DGX
Price
$107.52
$174.96
Analyst Decision
Buy
Analyst Count
0
13
Target Price
N/A
$196.69
AVG Volume (30 Days)
952.2K
1.1M
Earning Date
02-09-2026
01-29-2026
Dividend Yield
0.23%
1.81%
EPS Growth
N/A
14.49
EPS
6.86
8.51
Revenue
$18,266,000,000.00
$10,850,000,000.00
Revenue This Year
N/A
$12.37
Revenue Next Year
N/A
$3.52
P/E Ratio
$15.77
$20.71
Revenue Growth
6.06
13.74
52 Week Low
$78.98
$148.70
52 Week High
$109.06
$197.55

Technical Indicators

Market Signals
Indicator
L
DGX
Relative Strength Index (RSI) 61.00 34.97
Support Level $103.53 $174.59
Resistance Level $109.06 $177.24
Average True Range (ATR) 1.60 2.70
MACD 0.23 -0.86
Stochastic Oscillator 87.86 4.37

Price Performance

Historical Comparison
L
DGX

About L Loews Corporation

Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: